The pharmaceutical industry’s financial landscape is undergoing a significant transformation, marked by the continued brand dominance of Merck’s Keytruda (pembrolizumab)…
Read More
Pharma 50: The 50 Best-Selling Drugs of FY2025
The fiscal year 2025 concluded with a dramatic reshaping of the pharmaceutical industry’s top echelons, marked by intense competition at…
Read More
Sartorius’s CellCelector Flex Platform Revolutionizes Biotherapeutic Cell Line Development with Advanced Nanowell Technology and Automation
Developing robust and high-yielding cell lines for biotherapeutics is a critical yet challenging process in the field of biotechnology, forming…
Read More
Eli Lilly Ascends to Pharma’s Top Revenue Spot Amidst Oral GLP-1 Approval, Yet Wall Street Remains Unconvinced.
Eli Lilly and Company, a venerable titan in the pharmaceutical industry, has achieved an unprecedented milestone, claiming the top spot…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
Developing effective treatments for ultra-rare diseases has long presented a profound paradox for the biopharmaceutical industry and regulatory bodies. While…
Read More
A Billion-Dollar Telehealth Empire Built on Regulatory Cracks: The Medvi Controversy
Medvi, a telehealth company recently profiled by The New York Times as an AI-powered success story, is projected by its…
Read More
OpenClaw Emerges as a Pivotal Open-Source AI Agent System, Redefining Workflow Automation Across Industries.
The landscape of artificial intelligence is undergoing a significant transformation, moving beyond mere conversational interfaces to sophisticated, actionable agent systems.…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
In the wake of The New York Times’ April 2 profile, which painted MEDVi CEO Matthew Gallagher as a "vibe-coded…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Spotlights Pioneering Early-Stage Biotech Innovations Addressing Critical Unmet Medical Needs
Sai Life Sciences recently convened its highly anticipated Biotech Pitch Day 2026 at its strategically located Boston-area site, gathering a…
Read More
Beyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity market
The landscape of obesity treatment, a market projected to reach a staggering $1 trillion, is undergoing a profound transformation. While…
Read MoreYOU MAY HAVE MISSED
